Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
1999-05-04
2002-07-23
Witz, Jean C. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800
Reexamination Certificate
active
06423681
ABSTRACT:
BACKGROUND OF THE INVENTION
Throughout this application, various publications are referenced in parentheses by author and year. Full citations for these references may be found at the end of the specification immediately preceding the claims. The disclosures of these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
The kidney develops from two components, the metanephric mesenchyme and the ureteric bud. The ureteric bud invades the mesenchyme, triggering both mesenchymal proliferation and the conversion of the mesenchyme into epithelia. This process has been termed induction of the mesenchyme (Grobstein, 1955; Saxen, 1987; Ekblom, 1989). The bud is known to produce factors which stimulate growth of the metanephric mesenchyme (Perantoni et al., 1995; Barasch et al., 1997), but the ureteric factors which convert mesenchyme into epithelia have been unknown. To date, induction of isolated metanephric mesenchyme in vitro has been obtained with living cells, including a number of embryonic tissues (Grobstein, 1955; Sariola et al., 1989; Herzlinger et al., 1994; Kispert et al., 1998), but not with purified molecules.
To identify ureteric factors that trigger mesenchymal induction, we developed ureteric bud cell lines (UB cells; Barasch et al., 1996). These cells express a number of proteins in common with the embryonic ureteric bud at the time it invades the mesenchyme, including epithelial specific proteins (E-cadherin, ZO-1, cytokeratin, collagen IV, and laminin), receptor tyrosine kinases (c-ret and c-met), lectin (dolichos bifloris) binding sites (Barasch et al., 1996; Sakuri et al., 1997), as well as several monoclonal binding sites which cross react with the ureteric bud. In addition, UB cells secrete a number of metanephric mesenchymal growth factors (FGF-2, FGF-9, TIMP-1 and TIMP-2) that are also synthesized by the embryonic ureteric bud (Barasch et al, 1997; Barasch et al., 1999). We previously found that UB cells secrete factors (Barasch et al., 1997) that stimulate mesenchymal growth but cannot trigger metanephric mesenchymal conversion to epithelia.
The present application discloses the following. UB cells secrete several activities that in the presence of mesenchymal growth factors (Karavanova et al., 1996) trigger meserchymal to epithelial conversion and tubulogenesis. Purification and sequencing of one activity identified leukemia inhibitory factor (LIF). Metanephric mesenchymes treated with recombinant LIF (rLIF) were converted into epithelia and developed tubules as well as early nephrons. Other cytokines that signal through the gp130 receptor, like LIF, were also shown to induce epithelia. In vivo, LIF is expressed by the ureteric bud during invasion of the metanephric mesenchyme, while LIF receptors are expressed by the mesenchyme. Thus, as disclosed in the present application, LIF is a candidate mediator of epithelialization and morphogenesis in the embryonic kidney.
SUMMARY OF THE INVENTION
This invention is directed to a method of inducing the formation of kidney epithelia which comprises contacting mesenchymal precursors, in the presence of a growth factor, with an amount of a gp130 receptor ligand effective to induce the formation of kidney epithelia. This invention is the first disclosure of a method of inducing the formation of kidney epithelia with purified molecules.
This invention provides a method of inducing the differentiation of fetal tissue, fetal cells, or fetal or postnatal precursor or stem cells into kidney nephrons in a subject with diminished kidney function, which comprises administering to the subject, in the presence of a growth factor, an amount of a gp130 receptor ligand effective to induce differentiation of such fetal tissue, fetal cells, or fetal or postnatal precursor or stem cells into kidney nephrons.
This invention provides a method of treating a subject suffering from kidney failure which comprises administering to the subject, in the presence of a growth factor, an amount or a gp130 receptor ligand effective to treat the subject's kidney failure.
This invention provides a method of preserving a kidney for transplantation which comprises contacting the kidney, in the presence of a growth factor, with an amount of a gp130 receptor ligand effective to preserve the kidney.
REFERENCES:
patent: WO-0041713 (2000-07-01), None
Taupin et al., Tranplantation (Baltimore) 53(3): 655-658 (1992). Abstract.*
Hartner et al., Ann. N.Y. Acad. Sci 762: 424-425 (1995). Abstract.*
Wallner et al., Renal Failure 20(2): 331-341 (1998). Abstract.*
Hartner et al., Kidney International 45: 1562-1571 (1994).*
Morel et al., Cytokine 12(3): 265-271 (2000). Abstract.*
Bard et al., Development 113: 193-198 (1991).*
Barasch, J., L. Pressler, J. Connor, and A. Malik. 1996. A ureteric bud cell line induces nephrogenesis in two steps by two distinct signals.Am. J. Physiol.271: F50-F61 (Exhibit 2).
Barasch, J., J. Qioa, G. McWilliams, D. Chen, J.A. Oliver, and D. Herzlinger. 1997. Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis.Am. J. Physiol.273: F757-F767 (Exhibit 3).
Barasch, J., J. Yang, J. Qiao, P. Tempst, H. Erdjument-Bromage, W. Leung, J.A. Oliver. May, 1999. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.J. Clin. Invest.103: 1299-1307 (Exhibit 4).
Boccaccio, C., M. Ando, L. Tamagnone, A. Bardelli, P. Michieli, C. Battistini, and P.M. Comoglio. 1998. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway.Nature391: 285-288 (Exhibit 5).
Bonni, A., Y. Sun, M. Nadal-Vicens, A. Bhatt, D. A. Frank, I. Rozovsky, N. Stahl, G.D. Yancopoulos, and M.E. Greenberg. 1997. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.Science278: 477-483 (Exhibit 6).
Grobstein, C. 1955. Inductive interaction in the development of the mouse metanephors.J. Exp. Zool.130: 319-339 (Exhibit 7).
Gruenwald, P. 1943. Stimulation of nephrogenic tissue by normal and abnormal inductors.Anat. Rec.86: 321-335 (Exhibit 8).
Herzlinger, D., J. Qiao, D. Cohen, N. Ramakrishna, and A.M.C. Brown. 1994. Induction of Kidney epithelial morphogenesis by cells expressingWnt-1. Develop. Biol.166: 815-818 (Exhibit 9).
Karavanova, I.D., L.F. Dove, J.H. Resau, and A.O. Perantoni. 1996. Conditioned media from a rat ureteric bud cell line in combination with bFGF induces complete differentiation of isolated metanephric mesenchyme.Development122: 4159-4167 (Exhibit 10).
Kispert, A., S. Vainio, A.P. McMahon. 1998. Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney.Development125: 4225-4234 (Exhibit 11).
Mayer, M., Bhakoo, K., and M. Noble. 1994. Ciliary Neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitroDevelopment120: 143-153 (Exhibit 12).
Murphy, M., K. Reid, D.J. Hilton, and P.F. Bartlett. 1991. Generation of sensory neurons is stimulated by leukemia inhibitory factor.Proc. Natl. Acd. Sci. USA88: 3498-3501 (Exhibit 13).
Murphy, M., K. Reid, M.A. Brown, P.F. Bartlett. 1993 Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons.Development117: 1173-1182 (Exhibit 14).
Murphy, M., K. Reid, M.Ford, J. B. Furness, and P. F. Bartlett. 1994. FGF2 regulates proliferation of neural crest cells, with subsequent neuronal differentiation regulated by LIF or related factors.Development120: 3519-3528 (Exhibit 15).
Perantoni, A.O., L.F. Dove and I. Karavanova. 1995. Basic fibroblast growth factor can mediate the early inductive events in renal development.Proc. Natl. Acad. Sci.USA. 92: 4696-4700 (Exhibit 16).
Sariola, H., P. Ekblom, S. Henke-Fahle. 1989. Embryonic neurons as in vitro inducers of differentiation of nephrogenic mesenchyme.Devel. Biol.132: 271-281 (Exhibit 17).
Stark, K., S.
Barasch Jonathan M.
Oliver Juan A.
Yang Jun
Cooper & Dunham LLP
The Trustees of Columbia University in the City of New York
White John P.
Witz Jean C.
LandOfFree
Method of inducing formation of kidney epithelia from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing formation of kidney epithelia from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing formation of kidney epithelia from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2864545